initial public offerings (IPOs) trading on American exchanges

Friday, February 12, 2021

Athira Pharma (ATHA) began trading on the Nasdaq on Fri 18 Sept 20

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019.
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 63
  • Incorporated in 2011 
  • Headquartered in Bothell, Washington

No comments:

Post a Comment